During the past decade, WIP Warsaw IBD Point Profesor Kierkus conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 5 clinical trials were completed, i.e. on average, 10.9% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 5 clinical trials were completed. i.e. 15.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WIP Warsaw IBD Point Profesor Kierkus" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "Celgene" with 5 trials sponsored and "Galapagos NV" with 5 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WIP Warsaw IBD Point Profesor Kierkus" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Dr. Falk Pharma GmbH" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "WIP Warsaw IBD Point Profesor Kierkus" are "Ulcerative Colitis" (10 trials), "Crohn Disease" (9 trials), "Crohn's Disease" (9 trials), "Colitis, Ulcerative" (7 trials) and "Nonalcoholic Fatty Liver Disease" (3 trials). Many other conditions were trialed in "WIP Warsaw IBD Point Profesor Kierkus" in a lesser frequency.

Most popular intervention types in "WIP Warsaw IBD Point Profesor Kierkus" are "Drug" (43 trials), "Other" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Mirikizumab" (4 trials), "Ustekinumab" (4 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "WIP Warsaw IBD Point Profesor Kierkus" are 46 trials for "All" genders.

Currently, there are NaN active trials in "WIP Warsaw IBD Point Profesor Kierkus". undefined are not yet recruiting, 21 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in WIP Warsaw IBD Point Profesor Kierkus, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in WIP Warsaw IBD Point Profesor Kierkus, 4 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".